ERBITUX Side Effects

7022108-7 | Cellulitis
on Sep 22, 2010 Female patient from GERMANY , 59 years of age, was diagnosed with colon cancer and was treated with Erbitux (View Usage). Patient experienced the following unwanted or unexpected effects: cellulitis (What is cellulitis?). Erbitux dosage: 01-01sep2009 08sep09-23mar2010;400mg Recent: 16feb2010(22nd Inf). During the same period patient was treated with IRINOTECAN HCL (View Irinotecan Hcl Review and Irinotecan Hcl Label ), RESTAMIN (View Restamin Review and Restamin Label ), DECADRON (View Decadron Review and Decadron Label ), ZANTAC (View Zantac Review and Zantac Label ), KYTRIL (View Kytril Review and Kytril Label ). Patient was hospitalized.

7022101-4 | Renal Tubular Acidosis
Patient was taking Erbitux (View Usage). Patient had the following side effects: renal tubular acidosis on Sep 22, 2010 from GERMANY Additional patient health information: Female patient , 63 years of age, was diagnosed with colon cancer, colon cancer metastatic and. Erbitux dosage: Also Taken 400mg,250mg/m2(1in1 Wk) 400mg/m2 Loading Dose. During the same period patient was treated with OXALIPLATIN (View Oxaliplatin Review and Oxaliplatin Label ), CAPECITABINE (1400mg 850mg/m2 2 In 1 Day (1 To14 Days Every 3 Wks)) (View Capecitabine Review and Capecitabine Label ), IRINOTECAN HCL (400mg/m2 Loading Dose) (View Irinotecan Hcl Review and Irinotecan Hcl Label ), NEUPOGEN (View Neupogen Review and Neupogen Label ). Patient was hospitalized.

7022096-3 | Aphagia, C-reactive Protein Increased, Diarrhoea, Neutrophil Count Decreased
Adverse event was reported on Sep 22, 2010 by a Female patient taking Erbitux (View Usage) (Dosage: 400mg/m2 12mar-12mar2010, 19mar10-250 Mg/m2, Rec Inf On 26mar10) was diagnosed with rectal cancer and. Location: GERMANY , 59 years of age, weighting 116.8 lb, After Erbitux was administered, patient had the following side effects: aphagia, c-reactive protein increased, diarrhoea, neutrophil count decreased. During the same period patient was treated with IRINOTECAN HCL (Rec Inf On 26-mar-2010.) (View Irinotecan Hcl Review and Irinotecan Hcl Label ). Patient was hospitalized.

7019831-7 | Myocardial Infarction
on Sep 24, 2010 Male patient from UNITED STATES , 56 years of age, weighting 266.8 lb, was diagnosed with oesophageal adenocarcinoma and was treated with Erbitux (View Usage). Patient experienced the following unwanted or unexpected effects: myocardial infarction. Erbitux dosage: 250mg/m2 Iv Once A Week:6weeks,. During the same period patient was treated with CISPLATIN (25mg/m2:once A Week :6 Weeks Dose Adjusted Day 22 Returned To Full Dose Day 29) (View Cisplatin Review and Cisplatin Label ), TAXOL (50mg/m2 Iv Once A Week :6wks.) (View Taxol Review and Taxol Label ).


7018730-4 | Decreased Appetite, Dysphagia, Fatigue, Gastric Ulcer, Nausea, Oesophagitis, Stomatitis
on Sep 24, 2010 Male patient from UNITED STATES , 64 years of age, weighting 132.3 lb, was diagnosed with non-small cell lung cancer and was treated with Erbitux (View Usage). Patient had the following side effects: decreased appetite, dysphagia, fatigue, gastric ulcer, nausea (What is nausea?), oesophagitis, stomatitis. Erbitux dosage: 400mg/m2 Day 1 250mg/m2 Day 8; Last Dose: 14-sep-2010. During the same period patient was treated with CARBOPLATIN (Auc 2 And Auc 6;last Dose: 14-sep-2010) (View Carboplatin Review and Carboplatin Label ), TAXOL (45mg/m2 And 200mg/m2;last Dose: 14-sep-2010) (View Taxol Review and Taxol Label ), DECADRON (View Decadron Review and Decadron Label ), ZOFRAN (View Zofran Review and Zofran Label ). Patient was hospitalized.

7014820-0 | Dermatitis Acneiform, Diarrhoea, Dysphagia, Haemoglobin Decreased
Patient was taking Erbitux (View Usage). After Erbitux was administered, patient had the following side effects: dermatitis acneiform, diarrhoea, dysphagia, haemoglobin decreased on Sep 23, 2010 from UNITED STATES Additional patient health information: Male patient , 87 years of age, weighting 160.9 lb, was diagnosed with oesophageal adenocarcinoma and. Erbitux dosage: Last Dose On:03aug2010 400mg/m2;250mg/m2 On Day 8,15,22,29,36. During the same period patient was treated with CISPLATIN (Last Dose On:03aug2010 25mg/m2 On Day 1,8,15,22,29,36) (View Cisplatin Review and Cisplatin Label ), TAXOL (Last Dose On:03aug2010 50mg/m2 On Day 1,8,15,22,29,36) (View Taxol Review and Taxol Label ). Patient was hospitalized.

7014819-4 | Myocardial Infarction
Adverse event was reported on Sep 23, 2010 by a Male patient taking Erbitux (View Usage) (Dosage: 250mg/m2 Iv Once A Week:6weeks,) was diagnosed with oesophageal adenocarcinoma and. Location: UNITED STATES , 56 years of age, weighting 266.8 lb, Patient experienced the following unwanted or unexpected effects: myocardial infarction. During the same period patient was treated with CISPLATIN (25mg/m2:once A Week :6 Weeks Dose Adjusted Day 22 Returned To Full Dose Day 29) (View Cisplatin Review and Cisplatin Label ), TAXOL (50mg/m2 Iv Once A Week :6wks.) (View Taxol Review and Taxol Label ).

7014799-1 | Tumour Lysis Syndrome
on Sep 14, 2010 Male patient from GERMANY , 60 years of age, was diagnosed with rectal cancer metastatic and was treated with Erbitux (View Usage). Patient had the following side effects: tumour lysis syndrome. Erbitux dosage: . During the same period patient was treated with FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ). Patient was hospitalized.

7010831-X | Diarrhoea, Dysuria, Urinary Tract Infection
on Sep 23, 2010 Female patient from UNITED STATES , weighting 132.3 lb, was treated with Erbitux (View Usage). After Erbitux was administered, patient had the following side effects: diarrhoea, dysuria, urinary tract infection (What is urinary tract infection?). Erbitux dosage: 403 Mg. During the same period patient was treated with CISPLATIN (48 Mg) (View Cisplatin Review and Cisplatin Label ). Patient was hospitalized.

7008066-X | Anaemia, Dehydration, Febrile Neutropenia, Oesophageal Haemorrhage, Oesophageal Pain, Stomatitis, Vomiting
Patient was taking Erbitux (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, dehydration, febrile neutropenia, oesophageal haemorrhage, oesophageal pain, stomatitis, vomiting on Dec 17, 2009 from UNITED STATES Additional patient health information: Male patient , 76 years of age, weighting 156.5 lb, was diagnosed with oesophageal adenocarcinoma and. Erbitux dosage: 400mg/m2 On Day1;,1250mg/m2 On Days 8,15,22,29 And 36;total Dose Administered For This Course 3038mg. During the same period patient was treated with CISPLATIN (25mg/m2 On Day 1,8,15,22,29,36.total Dose For This Cours 212mg 3rd Dose Held And Last Dose Reduced) (View Cisplatin Review and Cisplatin Label ), TAXOL (50mg/m2 On D 1,8,15,22,29,36.total Dose For This Course 426mg 3rd Dose Held And Last Dose Reduced) (View Taxol Review and Taxol Label ). Patient was hospitalized.

7006521-X | Headache
Adverse event was reported on Sep 21, 2010 by a Female patient taking Erbitux (View Usage) (Dosage: ) was diagnosed with cervix carcinoma and. Location: UNITED STATES , 43 years of age, Patient had the following side effects: headache (What is headache?). Patient was hospitalized.

7003743-9 | Pneumoperitoneum, Rash
on Sep 17, 2010 Female patient from UNITED STATES , weighting 90.39 lb, was treated with Erbitux (View Usage). After Erbitux was administered, patient had the following side effects: pneumoperitoneum, rash (What is rash?). Erbitux dosage: .

6999803-9 | Dysphagia, Febrile Neutropenia, Neutrophil Count Decreased, Oesophageal Pain, Oesophagitis, Pain Of Skin, Radiation Skin Injury, Skin Infection, Stomatitis
on Sep 16, 2010 Male patient from UNITED STATES , 64 years of age, weighting 156.5 lb, was diagnosed with non-small cell lung cancer and was treated with Erbitux (View Usage). Patient experienced the following unwanted or unexpected effects: dysphagia, febrile neutropenia, neutrophil count decreased, oesophageal pain, oesophagitis, pain of skin, radiation skin injury, skin infection, stomatitis. Erbitux dosage: . During the same period patient was treated with CARBOPLATIN (Last Dose On 10aug2010(217mg) On Day 50 Last Dose Adm) (View Carboplatin Review and Carboplatin Label ), TAXOL (Last Dose On 10aug2010(85mg) On Day 50) (View Taxol Review and Taxol Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), MAGIC MOUTHWASH (View Magic Mouthwash Review and Magic Mouthwash Label ), SILVADENE (Cream) (View Silvadene Review and Silvadene Label ). Patient was hospitalized.

6997761-4 | Ascites
Patient was taking Erbitux (View Usage). Patient had the following side effects: ascites on Sep 14, 2010 from GERMANY Additional patient health information: Male patient , 53 years of age, was diagnosed with colon cancer and. Erbitux dosage: . During the same period patient was treated with IRINOTECAN HCL (Iv Infusion) (View Irinotecan Hcl Review and Irinotecan Hcl Label ). Patient was hospitalized.

6992251-7 | Febrile Neutropenia, Haemoglobin Decreased, Neutrophil Count Decreased, Platelet Count Decreased, White Blood Cell Count Decreased
Adverse event was reported on Sep 15, 2010 by a Male patient taking Erbitux (View Usage) (Dosage: 24aug10:570mg Received 560 Mg This Course.last Dose On 31aug2010.) was diagnosed with oesophageal adenocarcinoma and. Location: UNITED STATES , 80 years of age, weighting 211.6 lb, After Erbitux was administered, patient had the following side effects: febrile neutropenia, haemoglobin decreased, neutrophil count decreased, platelet count decreased, white blood cell count decreased. During the same period patient was treated with CISPLATIN (24aug10:55mg. Delayed 8 Dy Dose Reduced To 45mg.last Dose On 08sep2010) (View Cisplatin Review and Cisplatin Label ), TAXOL (24aug10:115mg. Delayed 8 Dy Received 112mg This Course.dose Reduced To 90mg.last Dose On 08sep2010) (View Taxol Review and Taxol Label ). Patient was hospitalized.

6992242-6 | Acute Respiratory Distress Syndrome, Fungal Infection, Interstitial Lung Disease, Pneumonia Primary Atypical, Respiratory Failure
on Aug 20, 2010 Female patient from GERMANY , 69 years of age, was diagnosed with colon cancer and was treated with Erbitux (View Usage). Patient experienced the following unwanted or unexpected effects: acute respiratory distress syndrome, fungal infection (What is fungal infection?), interstitial lung disease, pneumonia primary atypical, respiratory failure. Erbitux dosage: Total 7 Courses On May 28 Contin Inf For 2h On Day 1. During the same period patient was treated with OXALIPLATIN (85mg/m2 On Day 1(1 In 2wk), 7 Courses) (View Oxaliplatin Review and Oxaliplatin Label ), FOLINIC ACID (7 Courses) (View Folinic Acid Review and Folinic Acid Label ), FLUOROURACIL (7 Courses, 400mg/m2 Bolus Inf On Day 1 600mg/m2 Cont Inf For 22h On Day 1,2) (View Fluorouracil Review and Fluorouracil Label ), LEUCOVORIN CALCIUM (View Leucovorin Calcium Review and Leucovorin Calcium Label ). Patient was hospitalized.

6992203-7 | Acute Myocardial Infarction, Cardiac Arrest, Hypoxic-ischaemic Encephalopathy, Respiratory Arrest
on Sep 13, 2010 Male patient from UNITED STATES , 82 years of age, was diagnosed with colon cancer metastatic and was treated with Erbitux (View Usage). Patient had the following side effects: acute myocardial infarction, cardiac arrest (What is cardiac arrest?), hypoxic-ischaemic encephalopathy, respiratory arrest. Erbitux dosage: 765 Mg Was Expected To Be Infused. During the same period patient was treated with COUMADIN (View Coumadin Review and Coumadin Label ), COREG (1df-6.25(units Not Specified)) (View Coreg Review and Coreg Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), BENADRYL (View Benadryl Review and Benadryl Label ), ALOXI (View Aloxi Review and Aloxi Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ).

6988577-3 | Confusional State, Pancytopenia, Pneumonia
Patient was taking Erbitux (View Usage). After Erbitux was administered, patient had the following side effects: confusional state, pancytopenia, pneumonia (What is pneumonia?) on Sep 08, 2010 from GERMANY Additional patient health information: Male patient , 68 years of age, weighting 116.8 lb, was diagnosed with nasopharyngeal cancer and. Erbitux dosage: Total Dose 3076mg. During the same period patient was treated with CISPLATIN (Total Dose 238mg) (View Cisplatin Review and Cisplatin Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ). Patient was hospitalized.

6987475-9 | Fall, Foot Fracture, Platelet Count Decreased, Rash
Adverse event was reported on Sep 14, 2010 by a Female patient taking Erbitux (View Usage) (Dosage: ) . Location: UNITED STATES , 58 years of age, Patient experienced the following unwanted or unexpected effects: fall (What is fall?), foot fracture, platelet count decreased, rash (What is rash?). During the same period patient was treated with IRINOTECAN HCL (View Irinotecan Hcl Review and Irinotecan Hcl Label ), LABETALOL HCL (View Labetalol Hcl Review and Labetalol Hcl Label ), NIFEDIPINE (View Nifedipine Review and Nifedipine Label ), ARANESP (View Aranesp Review and Aranesp Label ).

6979001-5 | Confusional State
on Sep 01, 2010 Female patient from UNITED STATES , 57 years of age, weighting 141.1 lb, was diagnosed with non-small cell lung cancer and was treated with Erbitux (View Usage). Patient had the following side effects: confusional state. Erbitux dosage: . During the same period patient was treated with TAXOL (View Taxol Review and Taxol Label ), CARBOPLATIN (View Carboplatin Review and Carboplatin Label ). Patient was hospitalized.

6973503-3 | Decreased Appetite, Dehydration, Enteritis Infectious, Hypokalaemia, Hypophosphataemia, Lymphopenia, Nausea, Neutrophil Count Decreased, Sinus Tachycardia
on Sep 07, 2010 Male patient from UNITED STATES , 58 years of age, weighting 119.0 lb, was diagnosed with oesophageal carcinoma and was treated with Erbitux (View Usage). After Erbitux was administered, patient had the following side effects: decreased appetite, dehydration, enteritis infectious, hypokalaemia, hypophosphataemia, lymphopenia, nausea (What is nausea?), neutrophil count decreased, sinus tachycardia. Erbitux dosage: Cetuximab, Ini 400 Mg/m2 Iv Infusion Over 120 Minutes, Followed By Weeklyy Infusion Of 250mg/m2. During the same period patient was treated with TAXOL (Paclitaxcl, 5omg/m2, Iv Infusion Over 1 Hour Weekly On Day 1,8, 15,22,29 And 36.) (View Taxol Review and Taxol Label ), CISPLATIN (Cisplatin, 25mg/m2, Iv Infusion Over 30-60 Minutes Weekly On Day 1,8, 15, 22,29 And 36.) (View Cisplatin Review and Cisplatin Label ). Patient was hospitalized.

6973091-1 | Rash, Skin Exfoliation
Patient was taking Erbitux (View Usage). Patient experienced the following unwanted or unexpected effects: rash (What is rash?), skin exfoliation on Sep 07, 2010 from UNITED STATES Additional patient health information: Male patient , 62 years of age, was diagnosed with oesophageal carcinoma and. Erbitux dosage: Loading Dose-684 Mg On Day 1,428 Mg On Days 8,15,22,29,36.. During the same period patient was treated with CISPLATIN (Scheduled To Receive Dose On Days 1,8,15,22,29,36.) (View Cisplatin Review and Cisplatin Label ), PACLITAXEL (Scheduled To Receive Dose On Days 1,8,15,22,29,36.) (View Paclitaxel Review and Paclitaxel Label ).

6971269-4 | Febrile Neutropenia, Hypomagnesaemia, Neutrophil Count Decreased, Oesophagitis, Platelet Count Decreased, Vomiting
Adverse event was reported on Sep 03, 2010 by a Male patient taking Erbitux (View Usage) (Dosage: Dosage:loading Dose:400mg/m2*1 Dose Then 250mg/m2*5) was diagnosed with oesophageal carcinoma and. Location: UNITED STATES , 53 years of age, weighting 224.9 lb, Patient had the following side effects: febrile neutropenia, hypomagnesaemia, neutrophil count decreased, oesophagitis, platelet count decreased, vomiting. During the same period patient was treated with CISPLATIN (Dosage:25mg/m2) (View Cisplatin Review and Cisplatin Label ), TAXOL (Dosage:50mg/m2 Weekly *6doses) (View Taxol Review and Taxol Label ). Patient was hospitalized.

6971242-6 | Diarrhoea, Gastric Ulcer
on Aug 31, 2010 Female patient from GERMANY , 62 years of age, weighting 101.4 lb, was diagnosed with colon cancer, prophylaxis, supportive care and was treated with Erbitux (View Usage). After Erbitux was administered, patient had the following side effects: diarrhoea, gastric ulcer. Erbitux dosage: 500mg, 1 In 1 Wk (08jun09 + 17aug09) 300mg, 1 In 1 Wk (22jun09-06jul09). During the same period patient was treated with IRINOTECAN HCL (View Irinotecan Hcl Review and Irinotecan Hcl Label ), RESTAMINE (Tabs; 7.1429 Mg, 08jun-08jun, 22jun-06jul Also On 17aug09) (View Restamine Review and Restamine Label ), DECADRON (1.429 Mg, 08jun-08jun09, 22jun-06jul, 17aug-17aug) (View Decadron Review and Decadron Label ), ALESION (Tab, 2.8571mg; 08jun09-08jun09;22jun09-06jul09;17aug-17aug09) (View Alesion Review and Alesion Label ), KYTRIL (View Kytril Review and Kytril Label ), TAKEPRON (Tabs) (View Takepron Review and Takepron Label ). Patient was hospitalized.

6971241-4 | Supraventricular Tachycardia
on Aug 05, 2010 Male patient from GERMANY , 61 years of age, was diagnosed with colorectal cancer (What is colorectal cancer?) and was treated with Erbitux (View Usage). Patient experienced the following unwanted or unexpected effects: supraventricular tachycardia. Erbitux dosage: 8mar To 6apr10(28d) Ongoing. During the same period patient was treated with IRINOTECAN HCL (View Irinotecan Hcl Review and Irinotecan Hcl Label ), TRIMETON (View Trimeton Review and Trimeton Label ), KYTRIL (View Kytril Review and Kytril Label ), URBASON (View Urbason Review and Urbason Label ), TAREG (View Tareg Review and Tareg Label ).

6967550-5 | Toxic Epidermal Necrolysis
Patient was taking Erbitux (View Usage). Patient had the following side effects: toxic epidermal necrolysis on Aug 30, 2010 from GERMANY Additional patient health information: Male patient , 70 years of age, was diagnosed with nasopharyngeal cancer and. Erbitux dosage: Erbitux 5 Mg/ml.

6966951-9 | Chills, Cyanosis, Diarrhoea, Hypomagnesaemia, Livedo Reticularis, Metabolic Acidosis, Wheezing
Adverse event was reported on Sep 02, 2010 by a Female patient taking Erbitux (View Usage) (Dosage: Dose:week1-400mg/m2x1.57 628mg Over 90min, From Week2 250mg/m2x1.57 390mg Over 60min Every 2wks) was diagnosed with colon cancer metastatic and. Location: UNITED STATES , 82 years of age, After Erbitux was administered, patient had the following side effects: chills, cyanosis, diarrhoea, hypomagnesaemia, livedo reticularis, metabolic acidosis, wheezing. During the same period patient was treated with LEUCOVORIN CALCIUM (View Leucovorin Calcium Review and Leucovorin Calcium Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), OXALIPLATIN (View Oxaliplatin Review and Oxaliplatin Label ). Patient was hospitalized.

6966950-7 | Rash, Stomatitis, Toxic Epidermal Necrolysis
on Aug 30, 2010 Male patient from TAIWAN, PROVINCE OF CHINA , 49 years of age, weighting 132.3 lb, was diagnosed with head and neck cancer (What is head and neck cancer?), skin toxicity and was treated with Erbitux (View Usage). Patient experienced the following unwanted or unexpected effects: rash (What is rash?), stomatitis, toxic epidermal necrolysis. Erbitux dosage: Started: 12may08 Most Recent Infusion:10jun2008 600mg(12may08-19may08)-7d 400mg(26may08-10jun08). During the same period patient was treated with CISPLATIN (Started:12-may-2008 Most Recent Infusion: 10-jun-2008 19may08-10jun08 07jul08-21jul08(14d)) (View Cisplatin Review and Cisplatin Label ), MINOCYCLINE HCL (100mg (2 In 1 Day)) (View Minocycline Hcl Review and Minocycline Hcl Label ), TETRACYCLINE (View Tetracycline Review and Tetracycline Label ), CHLORPHENIRAMINE MALEATE (12may08-10jun08(29days) 16jun08-23jun08(7days)) (View Chlorpheniramine Maleate Review and Chlorpheniramine Maleate Label ), DEXAMETHASONE (12may08-12may08 16jun08-23jun08(7d) 14jul08-21jul08(7d)) (View Dexamethasone Review and Dexamethasone Label ), BETAMETHASONE (19may08-26may08(7d) 02jun08-10jun08(8d) 07jul08-) (View Betamethasone Review and Betamethasone Label ). Patient was hospitalized.

6966784-3 | Ocular Hyperaemia, Visual Acuity Reduced
on Aug 27, 2010 Male patient from GERMANY , 66 years of age, was diagnosed with colorectal cancer metastatic and was treated with Erbitux (View Usage). Patient had the following side effects: ocular hyperaemia, visual acuity reduced. Erbitux dosage: 5mg/ml; 1100mg 28apr9:29sep9, 154days; Last Inf-11mar2010,dosage:314.2857mg. During the same period patient was treated with LEUCOVORIN CALCIUM (View Leucovorin Calcium Review and Leucovorin Calcium Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), OXALIPLATIN (View Oxaliplatin Review and Oxaliplatin Label ).

6966775-2 | Febrile Neutropenia, Hypomagnesaemia, Neutrophil Count Decreased, Oesophagitis, Vomiting
Patient was taking Erbitux (View Usage). After Erbitux was administered, patient had the following side effects: febrile neutropenia, hypomagnesaemia, neutrophil count decreased, oesophagitis, vomiting on Sep 01, 2010 from UNITED STATES Additional patient health information: Male patient , 53 years of age, weighting 224.9 lb, was diagnosed with oesophageal squamous cell carcinoma and. Erbitux dosage: 400mg/m2:ivx1 250mglm2:ivweeklyx5;. During the same period patient was treated with CISPLATIN (25mg/m2:iv) (View Cisplatin Review and Cisplatin Label ), TAXOL (50mg/m2:ivweeklyx6 Doses) (View Taxol Review and Taxol Label ). Patient was hospitalized.

6966774-0 | Confusional State
Adverse event was reported on Sep 01, 2010 by a Female patient taking Erbitux (View Usage) (Dosage: ) was diagnosed with non-small cell lung cancer and. Location: UNITED STATES , 57 years of age, weighting 141.1 lb, Patient experienced the following unwanted or unexpected effects: confusional state. During the same period patient was treated with TAXOL (View Taxol Review and Taxol Label ), CARBOPLATIN (View Carboplatin Review and Carboplatin Label ). Patient was hospitalized.

6966433-4 | Pulmonary Haemorrhage
on Aug 31, 2010 Male patient from UNITED STATES , 60 years of age, weighting 176.4 lb, was diagnosed with non-small cell lung cancer and was treated with Erbitux (View Usage). Patient had the following side effects: pulmonary haemorrhage. Erbitux dosage: . During the same period patient was treated with CARBOPLATIN (Auc2) (View Carboplatin Review and Carboplatin Label ), TAXOL (View Taxol Review and Taxol Label ).

6966429-2 | Interstitial Lung Disease, Respiratory Failure
on Sep 02, 2010 Female patient from GERMANY , 69 years of age, was diagnosed with colon cancer and was treated with Erbitux (View Usage). After Erbitux was administered, patient had the following side effects: interstitial lung disease, respiratory failure. Erbitux dosage: Total 7 Courses On May 28 Contin Inf For 2h On Day 1. During the same period patient was treated with OXALIPLATIN (85mg/m2 On Day 1(1 In 2wk), 7 Courses) (View Oxaliplatin Review and Oxaliplatin Label ), LEUCOVORIN CALCIUM (7 Courses) (View Leucovorin Calcium Review and Leucovorin Calcium Label ), FLUOROURACIL (7 Courses, 400mg/m2 Bolus Inf On Day 1 600mg/m2 Cont Inf For 22h On Day 1,2) (View Fluorouracil Review and Fluorouracil Label ). Patient was hospitalized.

6964052-7 | Brain Oedema, Central Nervous System Lesion, Disease Progression, Dizziness, Headache, Influenza Like Illness, Mobility Decreased, Pneumonia
Patient was taking Erbitux (View Usage). Patient experienced the following unwanted or unexpected effects: brain oedema, central nervous system lesion, disease progression, dizziness (What is dizziness?), headache (What is headache?), influenza like illness, mobility decreased, pneumonia (What is pneumonia?) on Sep 02, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 129.0 lb, . Erbitux dosage: 2400 Mg. During the same period patient was treated with TAXOL (320 Mg) (View Taxol Review and Taxol Label ), CARBOPLATIN (1000 Mg) (View Carboplatin Review and Carboplatin Label ), AZITHROMYCIN (View Azithromycin Review and Azithromycin Label ), CEFIRIOXINE (View Cefirioxine Review and Cefirioxine Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ). Patient was hospitalized.

6962767-8 | Acne, Dehydration, Diarrhoea, Dizziness, Hiccups, Hypotension, Rash, Sepsis
Adverse event was reported on Aug 30, 2010 by a Male patient taking Erbitux (View Usage) (Dosage: ) . Location: UNITED STATES , 80 years of age, Patient had the following side effects: acne (What is acne?), dehydration, diarrhoea, dizziness (What is dizziness?), hiccups, hypotension, rash (What is rash?), sepsis (What is sepsis?). During the same period patient was treated with LISINOPRIL (View Lisinopril Review and Lisinopril Label ), TAXOL (View Taxol Review and Taxol Label ), CISPLATIN (View Cisplatin Review and Cisplatin Label ), PRAVASTATIN (View Pravastatin Review and Pravastatin Label ), REGLAN (View Reglan Review and Reglan Label ), KEFLEX (View Keflex Review and Keflex Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ).

6958212-9 | Chills, Dizziness, Erythema, Tremor
on Aug 30, 2010 Male patient from UNITED STATES , 66 years of age, was diagnosed with laryngeal cancer and was treated with Erbitux (View Usage). After Erbitux was administered, patient had the following side effects: chills, dizziness (What is dizziness?), erythema, tremor. Erbitux dosage: 100 Mg X 2.

6958089-1 | Decreased Appetite, Dehydration, Oesophagitis
on Aug 25, 2010 Male patient from UNITED STATES , 79 years of age, weighting 165.3 lb, was diagnosed with oesophageal adenocarcinoma and was treated with Erbitux (View Usage). Patient experienced the following unwanted or unexpected effects: decreased appetite, dehydration, oesophagitis. Erbitux dosage: . During the same period patient was treated with TAXOL (View Taxol Review and Taxol Label ), CISPLATIN (View Cisplatin Review and Cisplatin Label ). Patient was hospitalized.

6958048-9 | Febrile Neutropenia, Haemoglobin Decreased, Neutrophil Count Decreased, Platelet Count Decreased, White Blood Cell Count Decreased
Patient was taking Erbitux (View Usage). Patient had the following side effects: febrile neutropenia, haemoglobin decreased, neutrophil count decreased, platelet count decreased, white blood cell count decreased on Aug 26, 2010 from UNITED STATES Additional patient health information: Male patient , 80 years of age, weighting 211.6 lb, was diagnosed with oesophageal adenocarcinoma and. Erbitux dosage: Received 560 Mg This Course. During the same period patient was treated with CISPLATIN (View Cisplatin Review and Cisplatin Label ), TAXOL (Received 112mg This Course) (View Taxol Review and Taxol Label ). Patient was hospitalized.

6958044-1 | Arthralgia
Adverse event was reported on Aug 25, 2010 by a Male patient taking Erbitux (View Usage) (Dosage: 05aug10:400mg/m2 10aug10:250mg/m2 17aug10:250mg/m2) was diagnosed with lip and/or oral cavity cancer and. Location: UNITED STATES , 58 years of age, weighting 207.2 lb, After Erbitux was administered, patient had the following side effects: arthralgia. Patient was hospitalized.

6958041-6 | Interstitial Lung Disease, Respiratory Failure
on Aug 20, 2010 Female patient from GERMANY , 69 years of age, was diagnosed with colon cancer and was treated with Erbitux (View Usage). Patient experienced the following unwanted or unexpected effects: interstitial lung disease, respiratory failure. Erbitux dosage: Total 7 Courses On May 28 Contin Inf For 2h On Day 1. During the same period patient was treated with OXALIPLATIN (85mg/m2 On Day 1(1 In 2wk), 7 Courses) (View Oxaliplatin Review and Oxaliplatin Label ), FOLINIC ACID (7 Courses) (View Folinic Acid Review and Folinic Acid Label ), FLUOROURACIL (7 Courses, 400mg/m2 Bolus Inf On Day 1 600mg/m2 Cont Inf For 22h On Day 1,2) (View Fluorouracil Review and Fluorouracil Label ), LEUCOVORIN CALCIUM (View Leucovorin Calcium Review and Leucovorin Calcium Label ). Patient was hospitalized.

6957770-8 | Infection, Mucosal Inflammation, Oral Pain, Rash Papular, Skin Exfoliation
on Aug 30, 2010 Male patient from UNITED STATES , weighting 208.1 lb, was treated with Erbitux (View Usage). Patient had the following side effects: infection (What is infection?), mucosal inflammation, oral pain, rash papular, skin exfoliation. Erbitux dosage: 1918 Mg. Patient was hospitalized.

6955390-2 | Anaemia, Enteritis Infectious, Febrile Neutropenia
Patient was taking Erbitux (View Usage). After Erbitux was administered, patient had the following side effects: anaemia, enteritis infectious, febrile neutropenia on Aug 24, 2010 from GERMANY Additional patient health information: Male patient , 68 years of age, weighting 132.3 lb, was diagnosed with colon cancer, diabetes mellitus, enterocolitis, neuropathy peripheral and. Erbitux dosage: 200mg,1in3w Fm 04jn09-20ag10;200mg,1in1w 25jn-02jl09;200mg,1in3w 16jl09;200mg,1in1w 7-20ag09(13day). During the same period patient was treated with IRINOTECAN HCL (3rd And Recent Inf On 16jul09) (View Irinotecan Hcl Review and Irinotecan Hcl Label ), FLUOROURACIL (3250mg(inv Drip)from 04jun-16jul09) (View Fluorouracil Review and Fluorouracil Label ), LEUCOVORIN CALCIUM (View Leucovorin Calcium Review and Leucovorin Calcium Label ), AMARYL (Tabs) (View Amaryl Review and Amaryl Label ), BASEN (Tabs;also Intravenously;) (View Basen Review and Basen Label ), BIOFERMIN (Granules) (View Biofermin Review and Biofermin Label ), PYDOXAL (Tabs) (View Pydoxal Review and Pydoxal Label ), METHYCOOL (Methylcobalamin With Alpha Lactic Acid (tabs)) (View Methycool Review and Methycool Label ). Patient was hospitalized.

6943075-8 | Appendicitis Perforated
Adverse event was reported on Aug 23, 2010 by a Male patient taking Erbitux (View Usage) (Dosage: 400mg/m2 Day 1, 250mg/wk;last Dose On 26jul10 Interrupted On 02aug10) was diagnosed with non-small cell lung cancer and. Location: UNITED STATES , 61 years of age, weighting 149.9 lb, Patient experienced the following unwanted or unexpected effects: appendicitis perforated. During the same period patient was treated with CARBOPLATIN (45mg/m2/wk; Last Dose On 26jul10 Interrupted On 02aug10) (View Carboplatin Review and Carboplatin Label ), TAXOL (Auc Weekly; Last Dose On 26jul10 Interrupted On 02aug10) (View Taxol Review and Taxol Label ). Patient was hospitalized.

6941080-9 | Failure To Thrive, Nausea, Oesophageal Stenosis
on Aug 20, 2010 Female patient from UNITED STATES , 57 years of age, weighting 132.3 lb, was diagnosed with non-small cell lung cancer and was treated with Erbitux (View Usage). Patient had the following side effects: failure to thrive, nausea (What is nausea?), oesophageal stenosis. Erbitux dosage: Removed From Study On 02-aug-2010. During the same period patient was treated with CARBOPLATIN (Removed From Study On 02-aug-2010) (View Carboplatin Review and Carboplatin Label ), TAXOL (Removed From Study On 02-aug-2010) (View Taxol Review and Taxol Label ). Patient was hospitalized.

6937790-X | Feeling Cold, Heart Rate Decreased, Hyperhidrosis, Infusion Related Reaction, Nausea, Pruritus, Syncope
on Aug 20, 2010 Male patient from UNITED STATES , 54 years of age, weighting 191.0 lb, was diagnosed with head and neck cancer (What is head and neck cancer?) and was treated with Erbitux (View Usage). After Erbitux was administered, patient had the following side effects: feeling cold, heart rate decreased, hyperhidrosis, infusion related reaction, nausea (What is nausea?), pruritus, syncope. Erbitux dosage: 814 Mg Iv (loading Dose). During the same period patient was treated with WELLBUTRIN SR (View Wellbutrin Sr Review and Wellbutrin Sr Label ), LIPITOR (View Lipitor Review and Lipitor Label ), TENORMIN (View Tenormin Review and Tenormin Label ).

6936921-5 | Cardiovascular Disorder, Nausea
Patient was taking Erbitux (View Usage). Patient experienced the following unwanted or unexpected effects: cardiovascular disorder, nausea (What is nausea?) on Aug 12, 2010 from GERMANY Additional patient health information: Male patient , 60 years of age, . Erbitux dosage: .

6936857-X | Anaphylactic Reaction, Stupor
Adverse event was reported on Aug 19, 2010 by a Male patient taking Erbitux (View Usage) (Dosage: 250mg/m2) was diagnosed with head and neck cancer (What is head and neck cancer?) and. Location: UNITED STATES , 67 years of age, Patient had the following side effects: anaphylactic reaction, stupor. During the same period patient was treated with DEMEROL (View Demerol Review and Demerol Label ). Patient was hospitalized.

6936017-2 | Chills, Stupor
on Aug 19, 2010 Male patient from UNITED STATES , 67 years of age, was diagnosed with head and neck cancer (What is head and neck cancer?) and was treated with Erbitux (View Usage). After Erbitux was administered, patient had the following side effects: chills, stupor. Erbitux dosage: . During the same period patient was treated with DEMEROL (View Demerol Review and Demerol Label ). Patient was hospitalized.

6932583-1 | Cerebral Ischaemia, Fatigue, Infection
on Aug 18, 2010 Female patient from UNITED STATES , 76 years of age, was diagnosed with head and neck cancer (What is head and neck cancer?) and was treated with Erbitux (View Usage). Patient experienced the following unwanted or unexpected effects: cerebral ischaemia, fatigue, infection (What is infection?). Erbitux dosage: . During the same period patient was treated with ABRAXANE (View Abraxane Review and Abraxane Label ). Patient was hospitalized.

6932003-7 | Vomiting
Patient was taking Erbitux (View Usage). Patient had the following side effects: vomiting on Aug 12, 2010 from GERMANY Additional patient health information: Male patient , 45 years of age, was diagnosed with colon cancer metastatic, prophylaxis of nausea and vomiting and. Erbitux dosage: Recent Inf:17jun2010. During the same period patient was treated with IRINOTECAN HCL (Recent Inf:17jun2010) (View Irinotecan Hcl Review and Irinotecan Hcl Label ), FLUOROURACIL (Recent Inf:17jun2010) (View Fluorouracil Review and Fluorouracil Label ), PRIMPERAN TAB (1df=100mg/5ml) (View Primperan Tab Review and Primperan Tab Label ), SEVREDOL (View Sevredol Review and Sevredol Label ). Patient was hospitalized.